In Fatty liver with diabetes Fatty liver disease is a condition where there is an increased buildup of fat in the liver. This affects the functioning of the liver and makes you unhealthy. Hepexa M Tablet improves the overall health of the liver and helps it to perform its normal functions. Hepexa M Tablet also controls high blood glucose (sugar) levels. To make the medicine more effective and for general health benefits, try to avoid smoking and alcohol, maintain a healthy weight and indulge in some kind of exercise daily.
It is unsafe to consume alcohol with Hepexa M Tablet.
Hepexa M Tablet is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Hepexa M Tablet is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Hepexa M Tablet should be used with caution in patients with kidney disease. Dose adjustment of Hepexa M Tablet may be needed. Please consult your doctor. Use of Hepexa M Tablet is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.
Hepexa M Tablet should be used with caution in patients with liver disease. Dose adjustment of Hepexa M Tablet may be needed. Please consult your doctor. Hepexa M Tablet is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.
If you miss a dose of Hepexa M Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More